Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers?

Credit available for this activity expires: 9/22/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on new treatment options for thyroid eye disease?

Credit available for this activity expires: 9/17/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002870?ecd=bdc_podcast_libsyn_mscpedu

Discover how emerging B-cell-targeted therapies are transforming the treatment landscape and outcomes for patients with IgA nephropathy (IgAN).

Credit available for this activity expires: 9/18/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002833?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer?

Credit available for this activity expires: 9/10/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu

Do you know the latest in obesity management?

Credit available for this activity expires: 9/5/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002891?ecd=bdc_podcast_libsyn_mscpedu

Do you know where immunotherapy fits in the treatment paradigm of squamous cell anal carcinoma?

Credit available for this activity expires: 9/3/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002850?ecd=bdc_podcast_libsyn_mscpedu

The power to change lives and save lives: expert advice on how to recognize where action needs to be taken and what to do.

Credit available for this activity expires: 9/2/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002731?ecd=bdc_podcast_libsyn_mscpedu

Are you aware of the latest developments for treating EGFR mutation–positive advanced/metastatic NSCLC?

Credit available for this activity expires: 8/29/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002869?ecd=bdc_podcast_libsyn_mscpedu